A US biopharmaceutical company has been selected to receive a grant from the Michael J. Fox Foundation to develop gene therapy for Parkinson's disease (PD) and other rare diseases, according to reports from New York Times and the US state-run Financial Times.
Source: streetinsider.comPublished on 2022-08-24
Related news
- Visa invites startups in Asia Pacific to build next generation digital payment capabilities
- GSMA | Tackling the fastest growing waste stream : E - waste
- Space - based system can provide seismic monitoring for large earthquakes and tsunamis
- 5 Things you need to know today
- Europol gears up to collect big data on European citizens after MEPs vote to expand policing power -- Puppet Masters -- Sott . net
- Canada launches 2022 - 24 National Action Plan on Open Government
- TomTom co - founds Overture Maps Foundation to build Open Map Data
- Effects of the renewal on the StatFin database and its interfaces
- Dubai ranks among top five in the world for digital govt services : Sheikh Hamdan
- Mastercard Is Hiring Young Professionals to Expand Crypto and ESG Consulting
- Data Reform Bill announced in Queen Speech
- Travel Insurance Market to be Worth $63 . 9 Billion by 2030 : Grand View Research , Inc .
- Europol gears up to collect big data on European citizens after MEPs vote to expand policing power
- Portuguese energy distributor E - REDES selects Opendatasoft for new open data portal
- Autonomous & Self - Driving Vehicle News : AImotive , Embark , Foretellix , Plus , Innoviz , Hesai Partners , Kodiak Robotics , Cognizant , VW & Foresight